These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 16157194)
41. Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas. Shen H; Gao W; Wu YJ; Qiu HR; Shu YQ Biomed Pharmacother; 2009 Jul; 63(6):396-403. PubMed ID: 18848758 [TBL] [Abstract][Full Text] [Related]
42. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes. Kowalski J; Morsberger LA; Blackford A; Hawkins A; Yeo CJ; Hruban RH; Griffin CA Cancer Genet Cytogenet; 2007 Oct; 178(1):26-35. PubMed ID: 17889705 [TBL] [Abstract][Full Text] [Related]
43. Hydrogen peroxide degradation and selective carbidopa-induced cytotoxicity against human tumor lines. Gilbert JA; Frederick LM; Pobst LJ; Ames MM Biochem Pharmacol; 2005 Apr; 69(8):1159-66. PubMed ID: 15794936 [TBL] [Abstract][Full Text] [Related]
44. Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines. Whang-Peng J; Lee EC; Kao-Shan CS; Seibert K; Lippman M J Natl Cancer Inst; 1983 Oct; 71(4):687-95. PubMed ID: 6578363 [TBL] [Abstract][Full Text] [Related]
45. Establishment and characterization of human non-small cell lung cancer cell lines. Li J; Yang H; Chen L; Li Y; Zhu Y; Dai Y; Chen K; Ai J; Zeng T; Mao X; Liu L; Li X; Guan XY Mol Med Rep; 2012 Jan; 5(1):114-7. PubMed ID: 21971914 [TBL] [Abstract][Full Text] [Related]
46. Cell type-specific differences in metabolic activation of N-nitrosodiethylamine by human lung cancer cell lines. Schuller HM; Falzon M; Gazdar AF; Hegedus T IARC Sci Publ; 1987; (84):138-40. PubMed ID: 2824357 [TBL] [Abstract][Full Text] [Related]
47. Stimulation of the aberrant expression of a paraneoplastic antigen, recoverin, in small cell lung cancer cell lines. Bazhin AV; Savchenko MS; Belousov EV; Jaques G; Philippov PP Lung Cancer; 2004 Sep; 45(3):299-305. PubMed ID: 15301870 [TBL] [Abstract][Full Text] [Related]
48. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains. Olejniczak ET; Van Sant C; Anderson MG; Wang G; Tahir SK; Sauter G; Lesniewski R; Semizarov D Mol Cancer Res; 2007 Apr; 5(4):331-9. PubMed ID: 17426248 [TBL] [Abstract][Full Text] [Related]
49. A model for genetic complementation controlling the chromosomal abnormalities and loss of heterozygosity formation in cancer. Nestor AL; Hollopeter SL; Matsui SI; Allison D Cytogenet Genome Res; 2007; 116(4):235-47. PubMed ID: 17431320 [TBL] [Abstract][Full Text] [Related]
50. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer. Zhong S; Fields CR; Su N; Pan YX; Robertson KD Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644 [TBL] [Abstract][Full Text] [Related]
51. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes. Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686 [TBL] [Abstract][Full Text] [Related]
52. The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell lines. Balcer-Kubiczek EK; Attarpour M; Edelman MJ Cancer Chemother Pharmacol; 2007 May; 59(6):781-7. PubMed ID: 16957930 [TBL] [Abstract][Full Text] [Related]
53. Unbalanced translocation, a major chromosome alteration causing loss of heterozygosity in human lung cancer. Ogiwara H; Kohno T; Nakanishi H; Nagayama K; Sato M; Yokota J Oncogene; 2008 Aug; 27(35):4788-97. PubMed ID: 18408757 [TBL] [Abstract][Full Text] [Related]
54. [bcl-2 expression in small cell lung cancer: a mechanism for apoptosis antagonism and immune evasion]. Zheng JM; Wang DK; Jiang HM Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1537-9. PubMed ID: 16361157 [TBL] [Abstract][Full Text] [Related]
55. Molecular cytogenetic characterization of human papillomavirus16-transformed foreskin keratinocyte cell line 16-MT. McGhee EM; Cotter PD; Weier JF; Berline JW; Turner MA; Gormley M; Palefsky JM Cancer Genet Cytogenet; 2006 Jul; 168(1):36-43. PubMed ID: 16772119 [TBL] [Abstract][Full Text] [Related]
56. Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation. Morinaga R; Okamoto I; Furuta K; Kawano Y; Sekijima M; Dote K; Satou T; Nishio K; Fukuoka M; Nakagawa K Lung Cancer; 2007 Dec; 58(3):411-3. PubMed ID: 17601631 [TBL] [Abstract][Full Text] [Related]
57. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer. Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198 [TBL] [Abstract][Full Text] [Related]
59. Cytogenetic evaluation of a large series of hepatoblastomas: numerical abnormalities with recurring aberrations involving 1q12-q21. Tomlinson GE; Douglass EC; Pollock BH; Finegold MJ; Schneider NR Genes Chromosomes Cancer; 2005 Oct; 44(2):177-84. PubMed ID: 15981236 [TBL] [Abstract][Full Text] [Related]
60. [G-banded chromosome analysis of bone marrow and peripheral blood cells from small cell lung cancer (SCLC) patients]. Su Y; Wang XQ; Wu M; Tang ZZ; Kong LH; Wang YL; Chen LM Zhonghua Zhong Liu Za Zhi; 1987 Jul; 9(4):251-4. PubMed ID: 2824149 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]